Therefore, continued exploration of METTL3 or association of METTL3 with “specific sites” in ANGPTL3 mRNA might contribute to the development of new cancer therapies and lead to the development of a new pathway for effective METTL3 inhibition in gastric cancer. The gene discussed is ANGPTL3; the disease is cancer.